(RSTI) Strong Q4 FY2014 Results
PLYMOUTH, Mich. and HAMBURG, Germany, Nov. 13, 2014 — ROFIN-SINAR Technologies Inc. (NASDAQ: RSTI), one of the world’s leading developers and manufacturers of high-performance laser beam sources, laser-based system solutions and components, today announced results for its fourth fiscal quarter and twelve months ended September 30, 2014.
FINANCIAL REVIEW
– Fourth Quarter –
Net sales totaled $146.1 million for the fourth quarter ended September 30, 2014, slightly lower than in the fourth quarter of fiscal year 2013. Gross profit totaled $54.6 million, or 37% of net sales, compared to $50.2 million, or 34% of net sales, in the same period last fiscal year. RSTI net income amounted to $12.0 million, or 8% of net sales, compared to $9.8 million, or 7% of net sales, in the comparable quarter last fiscal year. The diluted earnings per share was $0.43 for the quarter based upon 28.1 million weighted-average common shares outstanding, compared to the diluted earnings per share of $0.35 based upon 28.4 million weighted-average common shares outstanding for the same period last fiscal year.
SG&A expenses in the amount of $27.1 million represented 19% of net sales and increased by $3.0 million, including one-time expenses of approximately $1.2 million, primarily associated with the expansion and modernization of production facilities, compared to last fiscal year’s fourth quarter. Net R&D expenses increased by $1.5 million to $11.5 million and represented 8% of net sales.
Sales of laser products for macro applications increased by 7% to $57.4 million and accounted for 39% of total sales. Sales of lasers for marking and micro applications decreased by 6% to $69.4 million and represented 48% of total sales. Sales of components decreased by 4% to $19.3 million and represented 13% of total sales.
On a geographical basis, revenues in North America decreased year-over-year by 7%, to $28.2 million and by 9% in Europe to $65.8 million, whereas net sales in Asia increased by 16% to $52.1 million.
– Twelve Months –
For the twelve months ended September 30, 2014, net sales totaled $530.1 million, a decrease of $30.0 million, or 5%, when compared to the prior fiscal year. The fluctuation of the US dollar, mainly against the Euro, resulted in an increase in net sales of $8.6 million for the twelve-month period. Gross profit for the period was $188.9 million and $7.6 million lower than in fiscal year 2013. RSTI net income for the fiscal year ended September 30, 2014, totaled $25.2 million. The diluted earnings per share was $0.89 based upon 28.2 million weighted-average common shares outstanding.
Net sales of lasers for macro applications decreased by $5.0 million, or 2%, to $209.6 million and net sales of lasers for marking and micro applications decreased by $22.5 million to $250.2 million. Sales of components decreased $2.5 million, or 3%, to $70.3 million compared to fiscal year 2013.
On a geographical basis, net sales in North America in the twelve months period decreased by 11% year-over-year and totaled $101.9 million (2013: $114.9 million). In Europe, net sales increased by 3% to $256.6 million (2013: $250.3 million) and in Asia, net sales decreased by 12% to $171.6 million (2013: $194.9 million).
– Order Backlog –
Order entry increased by 14% to $141.3 million for the quarter and by 4% to $553.4 million for the fiscal year compared to the corresponding periods in fiscal year 2013. The backlog, mainly for laser products, amounted to $141.3 million as of September 30, 2014. The book-to-bill ratio for the quarter was 0.97.
– Other Developments: Share Buyback –
During fiscal year 2014, the Company purchased approximately 0.3 million shares of common stock under the buyback program, announced in February 2014, for a total amount of $6.2 million.
– Outlook –
For the first quarter ending December 31, 2014, taking into account the anticipated impact of the average exchange rate, the Company expects sales to be in the range of $127 million to $132 million and earnings per share to be in the range of $0.28 to $0.30. At the mid-point of the guidance range, the first quarter outlook represents year-over-year growth of 7% in sales and 262% in earnings per share.
For the fiscal year ending September 30, 2015, taking into account the anticipated impact of the average exchange rate, the Company expects sales to range between $550 million and $570 million and earnings per share to be $1.60 at the mid-point of the sales range. This represents year-over-year growth of 6% in sales at the mid-point of the sales guidance range, and 80% in earnings per share. The Company confirmed its goal to achieve gross profit margin of 40% by the fourth quarter of fiscal year 2015. The improvement in results compared to the prior fiscal year will be a direct result of growth in sales of the Company’s next-generation products, including fiber lasers, and improved profitability from cost reduction measures and production economies of scale.
The Company’s first quarter and fiscal year 2015 guidance takes into account the expected unfavorable impact of the average exchange rate resulting from the recent strengthening of the US dollar, to the extent it continues. The majority of any such impact affects the sales level, with net income being affected to a lesser degree due to natural hedging.
Actual results may differ from this forecast and are subject to the safe harbor statement discussed in more detail below.
With almost 40 years of experience, ROFIN-SINAR Technologies is a leading developer, designer and manufacturer of lasers and laser-based system solutions for industrial material processing applications. The Company focuses on developing key innovative technologies and advanced production methods for a wide variety of industrial applications based on a broad scope of technologies. The product portfolio ranges from single laser-beam sources to highly complex systems, covering all of the key laser technologies such as CO2 lasers, fiber, solid-state and diode lasers, and the entire power spectrum, from single-digit watts up to multi-kilowatts, as well as a comprehensive spectrum of wavelengths or pulse durations and an extensive range of laser components. ROFIN-SINAR Technologies has its operational headquarters in Plymouth, Michigan, and Hamburg, Germany and maintains production facilities in the US, Germany, UK, Sweden, Finland, Switzerland, Singapore, and China. ROFIN currently has more than 49,000 laser units installed worldwide and serves more than 4,000 customers. The Company’s shares trade on the NASDAQ Global Select Market under the symbol RSTI and are listed in Germany in the “Prime Standard” segment of the Frankfurt Stock Exchange under ISIN US7750431022. ROFIN is part of the Standard & Poor’s SmallCap 600 Index and the Russell 2000 Index. Additional information is available on ROFIN-SINAR’s home page: www.rofin.com.
A conference call is scheduled for 11:00 AM Eastern Time, today, Thursday, November 13, 2014. This call is also being broadcast live over the internet in listen-only mode. The recording will be available on the Company’s home page for approximately 90 days. For a live webcast, please go to www.rofin.com at least 10 minutes prior to the call in order to download and install any necessary software. For more information, please contact Briget Ampudia, Taylor Rafferty, New York at +1-212-889-4350 or Miles Chapman, Taylor Rafferty, London at +44 (0) 207 614 2916.
The full text of the press release and further information including comprehensive financial data is available online at www.rofin.com.
“Safe Harbor” Statement Under the Private Securities Litigation Reform Act
Certain information in this press release that relates to future plans, events or performance, including statements such as “For the first quarter ending December 31, 2014, taking into account the anticipated impact of the average exchange rate, the Company expects sales to be in the range of $127 million to $132 million and earnings per share to be in the range of $0.28 to $0.30. At the mid-point of the guidance range, the first quarter outlook represents year-over-year growth of 7% in sales and 262% in earnings per share.” or “For the fiscal year ending September 30, 2015, taking into account the anticipated impact of the average exchange rate, the Company expects sales to range between $550 million and $570 million and earnings per share to be $1.60 at the mid-point of the sales range. This represents year-over-year growth of 6% in sales at the mid-point of the sales guidance range, and 80% in earnings per share. The Company confirmed its goal to achieve gross profit margin of 40% by the fourth quarter of fiscal year 2015. The improvement in results compared to the prior fiscal year will be a direct result of growth in sales of the Company’s next-generation products, including fiber lasers, and improved profitability from cost reduction measures and production economies of scale.” or “The majority of any such impact affects the sales level, with net income being affected to a lesser degree due to natural hedging.” is forward-looking and is subject to important risks and uncertainties that could cause actual results to differ. Actual results could differ materially based on numerous factors, including currency risk, competition, risk relating to sales growth in CO2, diode, and solid-state lasers, cyclicality, conflicting patents and other intellectual property rights of fourth parties, potential infringement claims and future capital requirements, as well as other factors set forth in our annual report on Form 10-K. These forward-looking statements represent the Company’s best judgment as of the date of this release based in part on preliminary information and certain assumptions which management believes to be reasonable. The Company disclaims any obligation to update these forward-looking statements.
TraderPower Featured Companies
- Annovis Bio Inc. (NYSE: ANVS)
- Astrotech Corp. (NASDAQ: ASTC)
- Cepton Inc. (NASDAQ: CPTN)
- Clene Inc. (NASDAQ: CLNN)
- CNS Pharmaceuticals Inc. (NASDAQ: CNSP)
- Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF)
- Fintech Ecosystem Development Corp. (NASDAQ: FEXD)
- Freight Technologies Inc. (NASDAQ: FRGT)
- InMed Pharmaceuticals Inc. (NASDAQ: INM)
- Lexaria Bioscience Corp. (NASDAQ: LEXX)
- McEwen Mining Inc. (NYSE: MUX) (TSX: MUX)
- Mullen Automotive Inc. (NASDAQ: MULN)
- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI)
Top Small Cap Market News
- $ANVS Annovis Bio Inc. (NYSE: ANVS) CEO Discusses Findings of Buntanetap Phase 2/3 Alzheimer’s Study on the Bell2Bell Podcast
- $SCNI InvestorNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Enters Into $2M Investment Commitment Agreement with Its Largest Existing Shareholder
- $INM InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Exciting INM-901 Data Providing ‘Attractive Therapeutic Approach’ in Alzheimer’s Treatment
- $SFWJ Hemp Industry Says Missouri Governor ‘Overreached’ When Banning Hemp Intoxicants
- $RFHRF InvestorNewsBreaks – Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF) (FSE: 9RR) Shares Update on Completed, Upcoming Exploration Activities
- $MUX InvestorNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Closes on Acquisition of Timberline Resources
- $ECGI InvestorNewsBreaks – ECGI Holdings Inc. (ECGI) Says Success of Allon Equestrian Apparel Line at AETA Is ‘Pivotal Moment’
Recent Posts
- $ECGI InvestorNewsBreaks – ECGI Holdings Inc. (ECGI) Says Success of Allon Equestrian Apparel Line at AETA Is ‘Pivotal Moment’
- $MUX InvestorNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Closes on Acquisition of Timberline Resources
- $RFHRF InvestorNewsBreaks – Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF) (FSE: 9RR) Shares Update on Completed, Upcoming Exploration Activities
- $SFWJ Hemp Industry Says Missouri Governor ‘Overreached’ When Banning Hemp Intoxicants
- $INM InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Exciting INM-901 Data Providing ‘Attractive Therapeutic Approach’ in Alzheimer’s Treatment
- $SCNI InvestorNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Enters Into $2M Investment Commitment Agreement with Its Largest Existing Shareholder
- $ANVS Annovis Bio Inc. (NYSE: ANVS) CEO Discusses Findings of Buntanetap Phase 2/3 Alzheimer’s Study on the Bell2Bell Podcast
- $FLGC CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Leveraging Colombia, US Facilities to Distinguish Itself Within Highly Competitive Space
Recent Comments
Archives
- August 2024
- January 2023
- June 2022
- December 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009